TRDA

ENTRADA THERAPEUTICS INC

TRDA·29384C108·US·Common Stock·Healthcare - Biotechnology-Activist

TRDA (ENTRADA THERAPEUTICS INC) is held by 80 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($37.3M), BlackRock, Inc. ($19M), VANGUARD CAPITAL MANAGEMENT LLC ($9.3M). Net institutional sentiment: Mixed.

80
Holders
(7 Elite)
$132.9M
Total Value
62% (81)
Consensus
50 buying - 31 selling
13F: Insider & Congress: Updated regularly
TRDA

Smart Money Verdict

View all
Loading verdict
Held by 80 funds
7 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 26, 2026 · Activists Aug 14, 2026 · Congress none

InsiderMLMPM BIOVENTURES 2018, L.P.Sell $103KAug 26, 2026
InsiderMLMPM BioVentures 2014, L.P.Sell $103KAug 26, 2026
InsiderMLMPM BIOVENTURES 2018, L.P.Sell $200KAug 25, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.1M$37.3M0.2%-60.81%
0
Increased
2.6M(+9.5%)$19M0.0%-54.79%
31
Increased
1.3M(+1.1%)$9.3M0.0%-40.69%
28
Decreased
954,419(-7.8%)$7M0.0%-46.91%
0
Increased
763,959(+47.1%)$5.6M0.0%+5.44%
37
Increased
717,430(+7.5%)$5.3M0.0%-50.17%
29
Increased
699,537(+780.0%)$5.1M0.0%-11.51%
44
Increased
596,677(+11.8%)$4.4M0.0%-50.54%
30
Increased
496,457(+3243.8%)$3.8M0.0%-4.55%
43
Increased
394,323(+83.4%)$2.9M0.0%+1.44%
41
Increased
376,136(+15.9%)$2.8M0.0%-41.10%
30
Increased
309,942(+31.9%)$2.3M0.0%-49.12%
33
Decreased
303,459(-9.1%)$2.2M0.0%-40.71%
0
Increased
254,130(+15.3%)$1.9M0.0%-37.81%
30
Decreased
197,136(-8.2%)$1.5M0.0%-52.22%
0
Increased
191,650(+8.8%)$1.4M0.0%-13.18%
28
Decreased
191,000(-5.5%)$1.4M0.0%-29.02%
0
Increased
188,839(+165.9%)$1.4M0.0%-2.95%
41
Decreased
177,343(-16.6%)$1.3M0.0%-31.79%
0
Increased
167,646(+6.9%)$1.2M0.0%-39.45%
27

Showing 1-20 of 88

1 / 5
TRDATRDAENTRADA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used